BYSIBeyondSpring Pharmaceuticals Inc.Not started yet
Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)
Non-Small Cell Lung Cancer · Non-squamous Non-Small Cell Lung Cance
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 3
- Patients
- 442 (planned)
- Started
- Dec 1, 2026
- Main results expected
- Jun 1, 2029
- Fully finished
- Dec 1, 2029
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Overall Survival (OS)
Measured over: Approximately 2 years after study initiation.
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT07361484 · record last updated 2026-09-29 · checked 2026-11-09 15:47 UTC